Riskpilot← Back to searchSign inGet full accessNURSECARE ApS
APSActiveCVR 10079152Valdemars Alle 82General medical practice activities · NACE 8621Est. 20016 employees
Revenue 2025
DKK 2,5M
+47% vs 2024
EBITDA margin
16.2%
+1277% vs 2024
Equity ratio
17.5%
Financial strength
Net profit 2025
DKK 304K
+6307% vs 2024
| Revenue | DKK 2,5M | +47% |
| EBITDA | DKK 410K | +1277% |
| Net profit | DKK 304K | +6307% |
| Total assets | DKK 1,5M | -26% |
| Equity | DKK 264K | +758% |
| Employees | 6 | — |
Legal name
NURSECARE ApS
CVR number
10079152
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
29. november 2001
Share capital
DKK 136.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive service, handel, industri og finansiering, herunder besiddelse af aktier og anparter i andre selskaber.
Address
Valdemars Alle 82
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -669 | -683 | 734 | 652 | 591 | 624 | 666 | 719 | 1.408 | 1.290 | 1.615 | 1.239 | 1.717 | 2.530 |
| Staff expenses | -577 | -324 | -337 | -361 | -383 | -516 | -632 | -575 | -713 | -1.050 | -1.370 | -1.546 | -1.687 | -2.120 |
| EBITDA | -92 | -360 | 397 | 291 | 208 | 108 | 35 | 144 | -60 | 240 | 246 | -306 | 30 | 410 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -92 | -360 | 397 | 291 | 208 | 108 | 35 | 144 | -60 | 240 | 246 | -306 | 30 | 410 |
| Net financials | -94 | -86 | -51 | -37 | -29 | -35 | 26 | -32 | 54 | 841 | -157 | -10 | -20 | -18 |
| Profit before tax | 2 | -274 | 346 | 254 | 179 | 73 | 61 | 112 | -6 | 1.081 | 89 | -316 | 10 | 392 |
| Tax | -2 | -77 | 87 | 68 | 49 | 13 | 14 | 27 | 1 | 241 | 23 | -69 | 5 | 88 |
| Net profit | 3 | -197 | 258 | 186 | 130 | 60 | 46 | 86 | -7 | 840 | 66 | -248 | 5 | 304 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 312 | 448 | 511 | 420 | 405 | 444 | 493 | 601 | 1.892 | 2.888 | 455 | 2.056 | 1.511 |
| Equity | — | 601 | -343 | -157 | -27 | 34 | 80 | 166 | 159 | 999 | 203 | -45 | -40 | 264 |
| Long-term debt | 0 | -337 | 242 | 0 | 247 | 0 | 0 | 0 | 0 | 0 | 78 | 1 | 0 | 25 |
| Short-term debt | 0 | -576 | 548 | 668 | 200 | 371 | 364 | 327 | 443 | 893 | 2.608 | 499 | 2.096 | 1.223 |
| Total debt | 0 | -913 | 790 | 668 | 447 | 371 | 364 | 327 | 443 | 893 | 2.686 | 500 | 2.096 | 1.247 |
EBITDA margin
16.2%
This company
15.8%
Market median
+3% vs market
20122025
Equity ratio
17.5%
This company
38.2%
Market median
-54% vs market
20122025
Return on equity
115.2%
This company
18.4%
Market median
+526% vs market
20122025
Net profit margin
12.0%
This company
8.1%
Market median
+48% vs market
20122025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20122025
Debt / equity
4.72×
This company
0.62×
Market median
-661% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
JB Management | Management | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2008 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MALA HOLDING ApS | Company | 50.0% | 50.0% | 2023 |
ComCap ApS | Company | 33.3% | 33.3% | 2023 |
Lasse Bjørk Holding ApS | Company | 10.0% | 10.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MALA HOLDING ApS
NURSECARE ApS Board members of NURSECARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mark Bjørk | Chief Executive Officer | 0 companies |
| John Bjørk | Management | 0 companies |
| Poul Bjarne Vinholt | Chairman | 0 companies |
| Charlotte Helene Stræde | Board of Directors | 0 companies |